Live Chat
Today's Hours: 8:00am - 10:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Journal
    Digital Access Full text via HathiTrust, 1000-
  • Book
    edited by Min P. Kim.
    Summary: The book demonstrates the step-by-step method of performing minimally invasive esophagectomy and robot-assisted esophagectomy. Chapters cover the techniques of performing minimally invasive and robot-assisted Ivor Lewis esophagectomy and McKeown esophagectomy as well as variation in methods of chest and neck anastomosis and a method to perform jejunostomy tube placement. Each author provides a narrative on their technique in performing the esophagectomy with pearls for different parts of the operation. As with any other surgical procedure, there are controversies about how to handle different parts of the operation. The goal of the book is not to debate the best method, but to provide a method to perform the complex operation in a minimally invasive way. Atlas of Minimally Invasive and Robotic Esophagectomy incorporates robot-assisted esophagectomy techniques and aims to benefit specialists and trainees that treat patients with esophageal cancer.

    Contents:
    Minimally Invasive and Robotic Esophagectomy
    Minimally Invasive Ivor Lewis Esophagectomy
    Minimally Invasive McKeown Esophagectomy
    Robot-assisted Ivor Lewis Esophagectomy
    Robot-assisted McKeown Esophagectomy
    Techniques of Chest Anastomosis
    Techniques of the Neck Anastomosis
    Robot-assisted Jejunostomy Tube Placement.
    Digital Access Springer 2021
  • Article
    Xabregas A, Gray L, Ham JM.
    Med J Aust. 1978 Jun 03;1(11):620-2.
    A double-blind controlled clinical trial of the efficacy of the prophylactic subcutaneous administration of calcium heparin in preventing deep vein thrombosis has been conducted in 50 patients with a fractured neck of the femur. Heparin was given every eight hours in a dose of 100 international units per kilogram of body weight and was commenced as soon as possible after the patient's admission to hospital. Treatment was continued for two weeks. In the placebo group, 12 of 25 patients developed a deep venous thrombosis and in five of these patients the thrombosis propagated to the thigh. There were no deep venous thromboses in the heparin-treated group during the two weeks of treatment, but four patients developed a deep venous thrombosis within a week of stopping the heparin. The heparin regime was safe; operative blood loss was not increased, nor was there an increased incidence of wound complications as compared to the placebo group.
    Digital Access Access Options